期刊文献+

沉默RANK真核表达载体的构建及有效干扰序列的筛选 被引量:1

Construction of eukaryotic expression vector with shRNA targeting RANK and screening for optimal shRNA
原文传递
导出
摘要 目的构建沉默小鼠RANK基因的真核表达载体pSuper-shRANK,筛选沉默RANK的最佳干扰序列。方法针对小鼠RANK基因设计并合成3对干扰序列,将其连接到真核表达载体pSuper上,酶切及测序鉴定正确后命名为pSuper-shRANK,后将其用脂质体瞬时转染小鼠骨髓巨噬细胞,用荧光显微镜观察转染情况,用Real-timePCR和Westernblot分析干扰效率。结果酶切分析与测序结果表明重组载体pSuper-shRANK构建成功,脂质体共转染后,Real-timePCR和Western blot分析结果显示shRANK-3干扰效果最好,干扰效率达88.7%,筛选出shRANK-3为最佳干扰序列。结论成功构建了沉默小鼠RANK基因的真核表达载体pSuper-shRANK;筛选出了沉默小鼠RANK的最佳干扰序列,为研究抑制该基因在破骨细胞分化及活化作用机制中奠定了基础。 Objective To construct an eukaryotic expression vector pSuper-shRANK with short hairpin RNA (shRNA) targeting mouse RANK gene,and to screen an optimal shRNA targeting RANK.Methods Three pairs of shRNAs targeting RANK were designed and synthesized,which were cloned into pSuper.After being confirmed by restriction enzyme digestion and sequencing methods,the recombinant plasmid was named as pSuper-shRANK,which was subsequently transfected into mouse bone marrow-derived macrophages (BMM) using Lipofectamine 2000.The optimal shRNA was selected among three pairs of shRNAs by RANK expression analysed by Real-time PCR and Western blot.Results Both restriction enzyme digestion and sequencing assays showed that the recombinant vector pSuper-shRANK was successfully constructed.The results of Real-time PCR and Western blot showed that shRANK-3 produced significant reduction (88.3%) on RANK expression (P〈0.01) among the three shRNAs.ConclusionsThe eukaryotic expression vector pSuper-retro-puro with shRNA targeting mouse RANK gene was successfully constructed and the optimal shRNA targeting RANK was also identified.This study has paved a way for future research on biological functions of mouse RANK gene,in particular its role in osteoclastogenesis of mouse BMMs.
出处 《中华关节外科杂志(电子版)》 CAS 2010年第5期49-53,共5页 Chinese Journal of Joint Surgery(Electronic Edition)
基金 广东省科技计划社会发展类项目(2008B030301321 2009B030801025)
关键词 RANK基因 RNA干扰 小鼠 骨髓 巨噬细胞 RANK gene RNA interference Mice Bone marrow Macrophages
  • 相关文献

参考文献16

  • 1Nakagawa N,Kinosaki M,Yamaguchi K,et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochem Biophys Res Commun,1998,253(2):395-400. 被引量:1
  • 2Purdue PE,Koulouvaris P,Nestor BJ,et al.The central role of wear debris in periprosthetic osteolysis.Hss J,2006,2(2):102-113. 被引量:1
  • 3Hannon GJ.RNA interference.Nature,2002,418(6894):244-251. 被引量:1
  • 4Anson DS.Retroviral mediated gene transduction.Methods Mol Biol,2001,175:471-494. 被引量:1
  • 5Takeshita S,Kaji K,Kudo A.Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.J Bone Miner Res,2000,15(8):1477-1488. 被引量:1
  • 6Eske K,Breitbach K,Khler J,et al.Generation of murine bone marrow derived macrophages in a standardised serum free cell culture system.J Immunol Methods,2009,342(1-2):13-19. 被引量:1
  • 7Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296(5567):550-553. 被引量:1
  • 8Takayanagi H,Ogasawara K,Hida S,et al.T cell mediated regulation of osteoclastogenesis by signalling cross talk between RANKL and IFN gamma.Nature,2000,408(6812):600-605. 被引量:1
  • 9Matsumoto M,Sudo T,Saito T,et al.Involvement of p38 mitogen activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF kappa B ligand (RANKL).J Biol Chem,2000,275(40):31155-31161. 被引量:1
  • 10Ikeda F,Nishimura R,Matsubara T,et al.Critical roles of c Jun signaling in regulation of NFAT family and RANKL regulated osteoclast differentiation.J Clin Invest,2004,114(4):475-484. 被引量:1

同被引文献17

  • 1Purdue PE,Koulouvaris P,Nestor BJ,et al.The central role of wear debris in periprosthetic osteolysis.Hss J,2006,2(2):102-130. 被引量:1
  • 2Nakagawa N,Kinosaki M,Yamaguchi K,et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochem Biophys Res Commun,1998,253(2):395-400. 被引量:1
  • 3Anson DS.Retroviral-mediated gene transduction.Methods Mol Biol,2001,175:471-494. 被引量:1
  • 4Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296(5567):550-553. 被引量:1
  • 5Hsu H,Lacey DL,Dunstan CR,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.Proc Natl Acad Sci USA,1999,96(7):3540-3545. 被引量:1
  • 6Canon JR,Roudier M,Bryant R,et al.Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.Clin Exp Metastasis,2008,25(2):119-129. 被引量:1
  • 7Shipman CM,Croucher PI.Osteoprotegerin is a soluble decoy receptor or tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.Cancer Res,2003,63(5):912-916. 被引量:1
  • 8Weiner LM.Fully human therapeutic monoclonal antibodies.J Immunotherapy,2006,29(1):1-9. 被引量:1
  • 9Takayanagi H,Ogasawara K,Hida S,et al.T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.Nature,2000,408(6812):600-605. 被引量:1
  • 10Matsumoto M,Sudo T,Saito T,et al.Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).J Biol Chem,2000,275(40):31155-31161. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部